Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer.
Head & neck(2023)
摘要
Older patients with T4 larynx cancer had similar survival rates when treated with CR, SR, and SCR. Average total health care costs were not significantly different between modalities. Patients not eligible for triple-modality could consider these other treatment options.
更多查看译文
关键词
HNSCC,Medicare,SEER,T4,larynx
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要